Edgen Stock·Nov 29 2025, 00:36返回
返回
Design Therapeutics 设定 DM1 药物试验 2026 年时间表，报告第三季度现金 2.06 亿美元
Edgen Stock·Nov 29 2025, 00:36
[1] Design Therapeutics 计划 2026 年上半年启动 DM1 患者给药 (https://www.streetinsider.com/Corporate+News/ ...)[2] 新闻稿 | Design Therapeutics, Inc (https://investors.designtx.com/news-and-event ...)[3] Design Therapeutics 将参加即将举行的投资者会议 (https://www.globenewswire.com/news-release/20 ...)